Retraction statement: 'Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c' [Cancer Science 152 (2014) 875-882] 10.1111/cas.12426;Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c

Cancer Science

Volumn 105, Issue 7, 2014, Pages 875-882

  Ye, Xianqing ^a   Jiang, Fei ^a   Li, Yuan ^a   Mu, Juan ^a   Si, Lu ^a   Wang, Xingxing ^a   Ning, Shilong ^a   Li, Zhong ^a  

^a Nanjing Medical University   (China)

Author keywords

Breast cancer; Epithelial mesenchymal transition; Glabridin; Metastasis; MicroRNA 200c

Indexed keywords

GLABRIDIN; MICRORNA 200C; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CELL INVASION; CELL MIGRATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL EPITHELIAL TRANSITION; MESENCHYME CELL; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; GLABRIDIN; METASTASIS; MICRORNA-200C;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOFLAVONES; MICE; MICE, INBRED BALB C; MICRORNAS; PHENOLS;

EID: 84904282127     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12578     Document Type: Erratum

References (37)

1. Tryggvadottir L, Gislum M, Bray F et al. Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49: 624-31.
2. Kang Y. Analysis of cancer stem cell metastasis in xenograft animal models. Methods Mol Biol 2009; 568: 7-19.
3. Redig AJ, McAllister SS. Breast cancer as a systemic disease: a view of metastasis. J Intern Med 2013; 274: 113-26.
4. Ahmad A, Sarkar SH, Bitar B et al. Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells. Mol Cancer Ther 2012; 11: 2193-201.
5. Yu XQ, Xue CC, Zhou ZW et al. In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice). Life Sci 2008; 82: 68-78.
6. Aoki F, Nakagawa K, Kitano M et al. Clinical safety of licorice flavonoid oil (LFO) and pharmacokinetics of glabridin in healthy humans. J Am Coll Nutr 2007; 26: 209-18.
7. Kim JY, Kang JS, Kim HM et al. Inhibition of bone marrow-derived dendritic cell maturation by glabridin. Int Immunopharmacol 2010; 10: 1185-93.
8. Ahn J, Lee H, Jang J, Kim S, Ha T. Anti-obesity effects of glabridin-rich supercritical carbon dioxide extract of licorice in high-fat-fed obese mice. Food Chem Toxicol 2013; 51: 439-45.
9. Tamir S, Eizenberg M, Somjen D et al. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res 2000; 60: 5704-9.
10. Nabekura T, Yamaki T, Ueno K, Kitagawa S. Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals. Cancer Chemother Pharmacol 2008; 62: 867-73.
11. Radisky DC. miR-200c at the nexus of epithelial-mesenchymal transition, resistance to apoptosis, and the breast cancer stem cell phenotype. Breast Cancer Res 2011; 13: 110.
12. Chen X, Xiao W, Chen W et al. The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells. Cell Death Dis 2013; 4: e884.
13. Huang Q, Gumireddy K, Schrier M et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008; 10: 202-10.
14. Oh JS, Kim JJ, Byun JY, Kim IA. Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys 2010; 76: 5-8.
15. Liang YJ, Wang QY, Zhou CX et al. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 2013; 34: 713-22.
16. Eades G, Yao Y, Yang M et al. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem 2011; 286: 25992-6002.
17. Tellez CS, Juri DE, Do K et al. EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res 2011; 71: 3087-97.
18. Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010; 15: 117-34.
19. Du J, Zhou N, Liu H et al. Arsenic induces functional re-expression of estrogen receptor alpha by demethylation of DNA in estrogen receptor-negative human breast cancer. PLoS ONE 2012; 7: e35957.
20. Franco-Chuaire ML, Magda Carolina SC, Chuaire-Noack L. Epithelial-mesenchymal transition (EMT): principles and clinical impact in cancer therapy. Invest Clin 2013; 54: 186-205.
21. Chen TC, Hsu YL, Tsai YC et al. Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells. J Mol Med 2014; 92: 53-64.
22. Hur K, Toiyama Y, Takahashi M et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut 2013; 62: 1315-26.
23. Carmeli E, Fogelman Y. Antioxidant effect of polyphenolic glabridin on LDL oxidation. Toxicol Ind Health 2009; 25: 321-4.
24. Shang H, Cao S, Wang J, Zheng H, Putheti R. Glabridin from Chinese herb licorice inhibits fatigue in mice. Afr J Tradit Complement Altern Med 2010; 7: 17-23.
25. Hsu YL, Wu LY, Hou MF et al. Glabridin, an isoflavan from licorice root, inhibits migration, invasion and angiogenesis of MDA-MB-231 human breast adenocarcinoma cells by inhibiting focal adhesion kinase/Rho signaling pathway. Mol Nutr Food Res 2011; 55: 318-27.
26. Tsai YM, Yang CJ, Hsu YL et al. Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/rho signaling pathway. Integr Cancer Ther 2011; 10: 341-9.
27. Castilla MA, Diaz-Martin J, Sarrio D et al. MicroRNA-200 family modulation in distinct breast cancer phenotypes. PLoS ONE 2012; 7: e47709.
28. Rajabi H, Alam M, Takahashi H et al. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition. Oncogene 2014; 33: 1680-9.
29. Engelsvold DH, Utheim TP, Olstad OK et al. miRNA and mRNA expression profiling identifies members of the miR-200 family as potential regulators of epithelial-mesenchymal transition in pterygium. Exp Eye Res 2013; 115: 189-98.
30. Chang CJ, Chao CH, Xia W et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 2011; 13: 317-23.
31. Golubovskaya VM, Finch R, Zheng M et al. The 7-amino-acid site in the proline-rich region of the N-terminal domain of p53 is involved in the interaction with FAK and is critical for p53 functioning. Biochem J 2008; 411: 151-60.
32. Lim ST, Chen XL, Lim Y et al. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell 2008; 29: 9-22.
33. Keely PJ. Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion. J Mammary Gland Biol Neoplasia 2011; 16: 205-19.
34. Iliopoulos D, Polytarchou C, Hatziapostolou M et al. MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci Signal 2009; 2: ra62.
35. Valastyan S, Weinberg RA. Roles for microRNAs in the regulation of cell adhesion molecules. J Cell Sci 2011; 124: 999-1006.
36. Baranwal S, Alahari SK. miRNA control of tumor cell invasion and metastasis. Int J Cancer 2010; 126: 1283-90.
37. Gregory PA, Bert AG, Paterson EL et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.